Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
In the field of cancer therapy, the emergence of targeted medications has brought new hope to many patients with advanced cancer. Sunitinib (Sunitinib, Sutent) is precisely such an···【more】
Article source：Captain MedicineRelease date：2026-09-28Recommended：182
Encorafenib is an oral BRAF inhibitor. All approved indications are combination regimens and require concomitant use with binimetinib or cetuximab, and must be based on confirmed B···【more】
Article source：Captain MedicineRelease date：2026-09-24Recommended：201
Encorafenib is mainly indicated for the treatment of metastatic melanoma harboring BRAF V600E or V600K mutations, metastatic colorectal cancer, and metastatic non-small cell lung c···【more】
Article source：Captain MedicineRelease date：2026-09-24Recommended：199
Whether individuals in special populations can use orforglipron and whether dosage adjustments are necessary must be comprehensively determined by a physician based on liver functi···【more】
Article source：Captain MedicineRelease date：2026-09-23Recommended：195
Orforglipron is taken once daily, swallowed whole, can be taken with or without food, and has no dietary or fluid restrictions. The three main things to monitor closely are: gastro···【more】
Article source：Captain MedicineRelease date：2026-09-23Recommended：238
The most common adverse reactions of Orforglipron are gastrointestinal effects—nausea, constipation, diarrhea, vomiting, dyspepsia, abdominal pain, abdominal distension, eructation···【more】
Article source：Captain MedicineRelease date：2026-09-22Recommended：209
Orforglipron is not a health supplement, nor is it a weight loss medication that you can buy and try on your own. It is a weight management drug that requires physician evaluation ···【more】
Article source：Captain MedicineRelease date：2026-09-22Recommended：220
Orforglipron is a prescription drug. The dosage and duration of treatment must be determined by an endocrinologist or a weight management physician. Do not adjust the dose, skip ti···【more】
Article source：Captain MedicineRelease date：2026-09-21Recommended：230
Orforglipron is an oral, small-molecule, non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist, approved by the US FDA in April 2026.Indications for OrforglipronOrforglipron···【more】
Article source：Captain MedicineRelease date：2026-09-21Recommended：220
When seeking medical consultation and receiving new prescription drugs, proactively inform your doctor that you are currently taking anagrelide. This includes medications prescribe···【more】
Article source：Captain MedicineRelease date：2026-09-20Recommended：206
In addition to taking Anagrelide itself, you also need to pay attention to following the scheduled follow-up checks, informing your doctor of all medications you are currently taki···【more】
Article source：Captain MedicineRelease date：2026-09-20Recommended：208
Lemborexant is a novel insomnia medication developed and manufactured by Eisai Co., Ltd. It is indicated for the treatment of adult patients with insomnia characterized by difficul···【more】
Article source：Captain MedicineRelease date：2026-09-18Recommended：203
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8542025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10512024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：3192026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4082026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：6032026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：5822026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4622026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6142026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
